Project Number 2R44AG051285-02A1 Agency/Funding Organization NIA Funding Year 2017 View Full Project Details for Novel, Orally-Available Prodrugs for Alzheimers Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) f. Inflammation Researcher and Organization Principal Investigator TAVARES, FRANCIS X Principal Investigator First Name FRANCIS Principal Investigator Last Name TAVARES Awardee Organization RESILIO THERAPEUTICS, LLC Awardee State North Carolina Contact PI Country United States Project Detail Funding Opportunity Announcement PA-16-302: PHS 2016-02 OMNIBUS SOLICITATION OF THE NIH, CDC, FDA AND ACF FOR SMALL BUSINESS INNOVATION RESEARCH GRANT APPLICATIONS (PARENT SBIR [R43/R44]) FY Overall Cost $983,466 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
